EA
Emerald Advisers Portfolio holdings
AUM
$2.73B
This Quarter Return
+11.52%
1 Year Return
+54.29%
3 Year Return
+280.05%
5 Year Return
+497.66%
10 Year Return
+2,067.91%
AUM
$2.38B
AUM Growth
+$2.38B
(-4.1%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-7.68%
Top 10 Holdings %
Top 10 Hldgs %
21.35%
Holding
276
New
33
Increased
40
Reduced
161
Closed
29
Top Buys
| 1 |
Modine Manufacturing
MOD
|
$26.1M |
| 2 |
Vital Farms
VITL
|
$16M |
| 3 |
InterDigital
IDCC
|
$14M |
| 4 |
Napco Security Technologies
NSSC
|
$13.8M |
| 5 |
Expro
XPRO
|
$13.4M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$72.8M |
| 2 |
Transmedics
TMDX
|
$30.1M |
| 3 |
Churchill Downs
CHDN
|
$27M |
| 4 |
Treace Medical Concepts
TMCI
|
$20.4M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$16.4M |
Sector Composition
| 1 | Technology | 24.67% |
| 2 | Healthcare | 22.79% |
| 3 | Industrials | 22.78% |
| 4 | Financials | 9.47% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Shift4
FOUR
$6.21B
| $28.8M | 1.21% | 393,180 -10,575 | -3% | -$776K |
|
27
Onto Innovation
ONTO
$5.19B
| $27.5M | 1.15% | 125,417 -29,835 | -19% | -$6.55M |
|
28
Madrigal Pharmaceuticals
MDGL
$9.76B
| $27.1M | 1.14% | 96,764 -4,859 | -5% | -$1.36M |
|
|
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $26.9M | 1.13% | 392,591 -9,020 | -2% | -$618K |
|
30
Impinj
PI
$5.45B
| $26.4M | 1.11% | 168,597 +4,608 | +3% | +$722K |
|
|
31
Modine Manufacturing
MOD
$7.15B
| $26.1M | 1.09% | +260,150 | New | +$26.1M |
|
32
Tidewater
TDW
$2.98B
| $25.7M | 1.08% | 270,023 +68,222 | +34% | +$6.5M |
|
33
NeoGenomics
NEO
$1.13B
| $25.6M | 1.07% | 1,844,615 -61,289 | -3% | -$850K |
|
|
34
Napco Security Technologies
NSSC
$1.36B
| $25.4M | 1.06% | 488,583 +264,789 | +118% | +$13.8M |
|
|
NVEE
35
DELISTED
NV5 Global
NVEE
| $25.3M | 1.06% | 271,946 -11,935 | -4% | -$1.11M |
|
36
Axos Financial
AX
$5.15B
| $25.3M | 1.06% | 442,086 -15,338 | -3% | -$877K |
|
37
Agilysys
AGYS
$3.06B
| $25M | 1.05% | 240,341 -7,526 | -3% | -$784K |
|
38
TriNet
TNET
$3.52B
| $25M | 1.05% | 250,168 -10,031 | -4% | -$1M |
|
39
Moelis & Co
MC
$5.35B
| $24.7M | 1.04% | 434,486 -18,339 | -4% | -$1.04M |
|
40
Louisiana-Pacific
LPX
$6.62B
| $23.9M | 1% | 289,697 +13,391 | +5% | +$1.1M |
|
41
Rambus
RMBS
$7.94B
| $23.2M | 0.97% | 394,961 +30,297 | +8% | +$1.78M |
|
42
Arhaus
ARHS
$1.65B
| $22.7M | 0.95% | 1,339,490 -52,193 | -4% | -$884K |
|
43
Kulicke & Soffa
KLIC
$1.96B
| $21.8M | 0.91% | 443,002 +161,791 | +58% | +$7.96M |
|
44
Ollie's Bargain Outlet
OLLI
$7.78B
| $21.5M | 0.9% | 219,404 +30,648 | +16% | +$3.01M |
|
45
Northern Oil and Gas
NOG
$2.55B
| $21.1M | 0.88% | 566,999 +84,751 | +18% | +$3.15M |
|
46
Collegium Pharmaceutical
COLL
$1.22B
| $20.9M | 0.88% | 650,173 -19,339 | -3% | -$623K |
|
47
Ultragenyx Pharmaceutical
RARE
$2.89B
| $20M | 0.84% | 486,682 -1,456 | -0.3% | -$59.8K |
|
48
BJ's Restaurants
BJRI
$742M
| $19.6M | 0.82% | 565,212 -21,049 | -4% | -$730K |
|
|
49
Churchill Downs
CHDN
$7.27B
| $19M | 0.8% | 136,305 -193,743 | -59% | -$27M |
|
50
Valaris
VAL
$3.54B
| $19M | 0.8% | 254,883 +28,933 | +13% | +$2.16M |
|